CHM and Parkinson disease: Seven small studies, including patients of European (n = 6)11–16 and Asian (n = 2)16,17 ancestry, did not find evidence that the SNCA REP1-risk genotype impacts AAO in PD (Fig. 2 and Supplementary Table 3).